Abstract:In this study, for the first time, by employing a simple and efficient double nano-emulsification method and using sweet almond oil as the organic phase, polyethylene glycol (PEG)/graphene oxide (GO)/silk fibroin (SF) hydrogel-nanocomposite was synthesized. The aim of the research was to fabricate a biocompatible targeted pH-sensitive sustained release carrier, improve the drug loading capacity and enhance the anticancer effect of doxorubicin (DOX) drug. The obtained values for the entrapment (%EE) and loading efficacy (%LE) were 87.75 ± 0.7 % and 46 ± 1 %, respectively, and these high values were due to the use of GO with a large specific surface area and the electrostatic interaction between the drug and SF. The Fourier transform infrared spectroscopy (FTIR) and X-ray diffraction (XRD) analyses confirmed the presence of all the components in the nanocomposite and the suitable interaction between them. Based on the results of dynamic light scattering analysis (DLS) and zeta potential analysis, the mean size of the carrier particles and its surface charge were 293.7 nm and -102.9 mV, respectively. The high negative charge was caused by the presence of hydroxyl groups in GO and SF and it caused proper stability of the nanocomposite. The spherical core-shell structure with its homogeneous surface was also observed in the field emission scanning electron microscopy (FE-SEM) image. The cumulative release percentage of the nanocarrier reached 95.75 after 96 h and it is higher in the acidic environment at all times. The results of fitting the release data to the kinetic models suggested that the mechanism of release was dissolution-controlled anomalous at pH 7.4 and diffusion-controlled anomalous at pH 5.4. The results of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay and flow cytometry showed an increase in toxicity on MCF-7 cells and improved apoptotic cell death compared to the free drug. Consequently, the findings of this research introduced and confirmed PEG/GO/SF nanocomposite as an attractive novel drug delivery system for pH-sensitive and sustained delivery of chemotherapeutic agents in biomedicine.

Green one-pot synthesis of carboxymethylcellulose/Zn-based metal-organic framework/graphene oxide bio-nanocomposite as a nanocarrier for drug delivery system

Chitosan coated MOF/GO nanohybrid as a co-anticancer drug delivery vehicle: Synthesis, characterization, and drug delivery application

One-pot, sustainable and room temperature synthesis of graphene oxide-impregnated iron-based metal-organic framework (GO/MIL-100(Fe)) nanocarriers for anticancer drug delivery systems

Cu (II)-porphyrin metal-organic framework/graphene oxide: synthesis, characterization, and application as a pH-responsive drug carrier for breast cancer treatment

Carboxymethyl cellulose modified graphene oxide as pH-sensitive drug delivery system.

Carboxymethyl Cellulose-Grafted Graphene Oxide for Efficient Antitumor Drug Delivery

Sodium Alginate Conjugated Graphene Oxide As a New Carrier for Drug Delivery System

Fabrication and Antitumor Mechanism of a Nanoparticle Drug Delivery System: Graphene Oxide/Chitosan Oligosaccharide/γ‐Polyglutamic Acid Composites for Anticancer Drug Delivery

Preparation of Nanostructured Graphene Oxide and Its Application in Drug Loading and Sustained Release

Development of a graphene oxide-poly lactide nanocomposite as a Smart Drug Delivery System

Synthesis and characterization of a novel, pH-responsive sustained release nanocarrier using polyethylene glycol, graphene oxide, and natural silk fibroin protein by a green nano emulsification method to enhance cancer treatment

Graphene oxide-templated biomineralization nanosystem enables multi-drug loading and controllable release

Multi-functionalized Graphene Oxide Based Anticancer Drug-Carrier with Dual-Targeting Function and Ph-Sensitivity

Stability, Cellular Uptake, and in Vivo Tracking of Zwitterion Modified Graphene Oxide As a Drug Carrier

A Targeted Nano Drug Delivery System of AS1411 Functionalized Graphene Oxide Based Composites

Doxorubicin-loaded graphene oxide nanocomposites in cancer medicine: stimuli-responsive carriers, co-delivery and suppressing resistance

A l-lysine-coated graphene oxide/magnetic hydroxyapatite/cubic metal-organic frameworks for targeted and pH-controlled release of doxorubicin to cancer cells

A New Anti-Cancer Drug Delivery System: Polymeric Ionic Liquid Functionalized Reduced Graphene Oxide

Simple method for fabrication of metal-organic framework within a carboxymethylcellulose/graphene quantum dots matrix as a carrier for anticancer drug

Biofunctionalized graphene oxide nanosheet for amplifying antitumor therapy: Multimodal high drug encapsulation, prolonged hyperthermal window, and deep-site burst drug release

Functional Materials From The Covalent Modification Of Reduced Graphene Oxide And Beta-Cyclodextrin As A Drug Delivery Carrier